Precision Wellness in Silicon Valley has validated a cardiometabolic disease predictive risk engine to accurately predict an individual’s future state of health. The study was performed as part of sponsored precision medicine research with Stanford University to evaluate nearly 417,000 individuals from a United Kingdom Biobank population that was tracked for six years. Risk models that were validated include Type 2 diabetes, stroke, coronary artery disease, abdominal aortic aneurysm and deep vein thrombosis. The economic burden and growing rate of…